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115* First European CF microbiology quality assurance trial
M. Hogardt1, D. Claus2, H. Riehn-Kopp3, B. Tu¨mmler3. 1Max-von Pettenkofer-
Institut, LMU, Mu¨nchen, Germany; 2Universita¨t, Go¨ttingen, Germany; 3Klinische
Forschergruppe, MedHo, Hannover, Germany
The identiﬁcation of microbial species from respiratory specimens and their suscep-
tibility to antimicrobial agents belong to the most important diagnostic measures
of CF care. Under the umbrella of EuroCareCF the ﬁrst quality assurance trial
on CF microbiology was performed in autumn 2007. Of 53 invited large CF
clinics and their clinical microbiology services all of which belonging to the
largest and most renowned CF centers in their home country, 35 CF microbiology
laboratories agreed to participate. Five formulations with CF bacterial isolates
were dispatched. 31 laboratories from 18 European countries returned the report
specifying the identiﬁed bacterial species and their antimicrobial susceptibility
proﬁles. The common CF pathogens Pseudomonas aeruginosa and Staphylococcus
aureus were correctly identiﬁed by almost all participants even if the strains
presented uncommon phenotypes. A Burkholderia cenocepacia IIIB CF isolate was
recognized at the level of the B. cepacia complex by 20 laboratories, but only
few participants correctly assigned species and respective recA lineage/genomovar.
Emerging pathogens such as Achromobacter xylosoxydans or Pandoraea pnomenusa
were not detected or misclassiﬁed by many laboratories. Five participants correctly
identiﬁed all CF isolates up to the species level and 18 participants provided
appropriate recommendations for antimicrobial chemotherapy and infection control
measures for a difﬁcult-to-treat CF subject. The identiﬁed shortcomings in the
translational service and in the diagnostics of rare and/or emerging pathogens point
to the need for further/regular quality control trials and continuing education in CF
microbiology and suggest the set-up of CF microbiology reference laboratories.
Supported by: EU.
116* Patient-to-patient transmission of a multiresistant Pseudomonas
aeruginosa strain in a summer camp detected by prospective
follow up
F. Karpati1, P. Meyer2, V. Adermark1, E. Johansson3, C. Welinder-Olsson3. 1CF
Centre, Karolinska Univ. Hospital, Huddinge, Stockholm, Sweden; 2CF Centre,
Univ. Hospital, Lund, Lund, Sweden; 3Clinical Bacteriology, Sahlgrenska Univ.
Hospital, Go¨teborg, Sweden
Objectives: Cystic ﬁbrosis (CF) patients are at risk of chronic infection with Pseu-
domonas aeruginosa (P.a.), most frequently by environmental strains. Transmission
of strains also occurs despite precautions.
After a summer camp in 2005, organized for teenagers from Stockholm CF Centre
(SCFC), some cases of cross-infection were suspected due to exacerbation or
emerging sputum culture ﬁndings.
Methods: P.a. isolates were prospectively typed by pulsed-ﬁeld gel electrophoresis
(PFGE) and also by multiple-locus variable number tandem repeat analysis (MLVA).
Results: Five patients were found to be newly colonized with an identical mul-
tiresistant P.a. strain, assigned to cluster J by PFGE (MLST242) and shown to be
unique for Swedish CF patients. Both changes from other colonising strains and
infection in formerly not infected patients occurred. Cohort segregation has been
introduced. Lung function tests did not show deterioration (FEV1 changed from
81.6% of predicted to 87.8% after one year and to 91.6% at the latest follow up),
nor the chest x-rays showed worsening. The choice of antibiotics was limited by
the resistance pattern of the isolated strains. No spread of this epidemic strain was
observed at SCFC during follow up.
Conclusion: Cross-infection by transmissible P.a. strains occurs in camps despite
hygienic regulations due to suboptimal compliance. This is the second case of
patient-to-patient transmission of P.a. strains belonging to the multiresistant Swedish
J-cluster. Longer follow up may be necessary for an accurate estimation of the
consequences of a transmission.
117 Cross-infection of Pseudomonas aeruginosa during an open air
meeting on the beach
G. Ruiter1, A. Terlingen2, A. Fleer2, H.G. Arets1. 1Paediatric Pulmonology,
University Medical Centre Utrecht, Utrecht, Netherlands; 2Clinical Microbiology,
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Colonisation with Pseudomonas is associated with decrease of pulmonary condition
and lung function. Segregation policies have been instituted to prevent cross-
infection with this and other respiratory pathogens. It is not well known if short
term open air contact between CF patients has a comparable risk of cross infection.
Nevertheless the segregation policy a small cohort of CF patients in the Netherlands
organizes a yearly open air music festival on the beach (CF Beach Dance). We
analysed the risk of cross-infection during the CF Beach Dance 2006.
Methods: Sputum cultures were collected at the beginning and end of the festival
and 4−6 weeks later. Pseudomonas strains were phenotyped by pulsed ﬁeld gel
electrophoresis (PFGE) using Tenover criteria.
Results: In 68 cultures of 22 patients we found 129 Pseudomonas strains (38
mucoid). The 126 strains that could be phenotyped by PFGE belonged to 14
clusters, 31 pulsotypes and 73 subtypes using Tenovercriteria. All 22 CF patients
were Pseudomonas positive at the start. In the second culture we found a strongly
increased strain variation (36 versus 24 in the ﬁrst and 22 in the last cultures. 6
patients had new strains in the second culture, that were absent again in the follow
up culture. In 1 patient persistent colonisation with a new strain was found. This
strain had been present in 50% of other patients at the start of the festival. An extra
culture after 10 weeks conﬁrmed the presence of this strain.
Conclusion: Cross infection with Pseudomonas can not be excluded, also after
short term open air contact between CF patients. In most patients contamination
appears to result in short term intermittent colonisation.
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Introduction: We performed a 7-year prospective study of clinical outcome for CF
patients infected with transmissible and sporadic strains of P. aeruginosa.
Methods: At MACFC, patients with P. aeruginosa infection who required in-patient
treatment during the last 6 months of 1999 were studied prospectively for 7 years
from April 2000–2007. Patients were grouped into those infected with sporadic
(Gp1) and transmissible (Gp2) strains.
Results: 80 patients were studied, 52 in Gp1 (30 male, 22 female) and 28 in
Gp2 (11 male, 17 female). There were no differences between the groups in mean
%FEV1, %FVC, age or BMI at baseline. Over 7 years there were no difference in
deaths/lung transplants in Gp1 9/4 and Gp2 6/2 (p = 0.73), or overall survival with
81% and 78% of patients alive in Gp 1 and Gp2 respectively (p = 0.94). 13 Gp 1
patients became super-infected with a transmissible strain of P. aeruginosa. 2 Gp
1 patients acquired infection with Burkholderia species. 3 Gp 1 patients moved to
another area and were lost to follow up.
For Gp 1 (n = 21) and Gp 2 (n = 20) patients with 7 year survival data there were
again no differences in mean %FEV1, %FVC, age or BMI at baseline. At 7-year
follow-up, Gp 1 patients had fewer IV antibiotic days (mean (SD) 30.1 [21.5] v 51.8
[38.9] days) (p = 0.01), and fewer annual inpatient treatment days (median [range]
9.7 [1.5, 48.7] v 24.6 [7.3, 67.8] days) (p< 0.01) than Gp2 patients. There was
no difference in number of clinic visits, change in mean %FEV1, %FVC or BMI
between the groups.
Conclusion: Patients with CF infected with transmissible strains of P. aeruginosa
have an increase in morbidity but no increase in mortality above those infected with
sporadic P. aeruginosa strains.
